nigericin has been researched along with Lung Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Huang, D; Pei, C; Shen, Z; Shi, S; Wang, M; Wang, X; Wang, Y; Wang, Z; Wu, Y | 1 |
1 other study(ies) available for nigericin and Lung Diseases
| Article | Year |
|---|---|
Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome-mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice.
Topics: Animals; Caspase 1; Inflammasomes; Lung; Lung Diseases; Mice; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Particulate Matter; Pneumonia; Pyroptosis; Saponins; Signal Transduction; Triterpenes | 2022 |